Abstract
The current consensus is that 2 doses of mRNA vaccines against SARS-CoV-2 are needed for people without COVID-19 history, while for those who had suffered COVID-19, a single dose may be enough to achieve high levels of immunization. This consensus has been based on results obtained in middle-aged populations, whereas only few data exist for the oldest and most frail adults such as nursing home residents (NH-Res) that is, the population most vulnerable to develop severe forms of COVID-19.
In this study, we studied the anti-SARS-CoV-2 IgG(S) level of NH-Res and healthcare workers (HCWs) with or without a history of COVID-19 infection taking into account the time since immunization (COVID-19 and/or vaccination). 654 subjects were analyzed: 397 NH-Res (median age 88, IQR 82-93 years, 75% women) and 257 Health Care Workers (HCWs, median 46, IQR 38-54 years, 81% women). NH-Res and HCWs were classified in one of the following 3 groups: No-COVID history and 2 vaccine shots (COV-NO/2VACC); Yes-COVID history and 1 (COV-YES/1VACC) or 2 (COV-YES/2VACC) vaccine injections.
The time-related decrease in IgG (S) in subjects without COVID-19 history, SARS-COV-2 serology would be negative in HCWs approximately 220 days and in residents 180 days after vaccination. This time-related decrease was much slower in those with history of COVID. NH-Res belonging into the COV-NO/2VACC and the COV-YES/1VACC groups showed lower IgG (S) levels than the same groups of HCWs (for both groups, p<0.0001), whereas in the group COV-YES/2VACC, IgG (S) levels were similar in NH-Res and HCWs (p=0.88). These results remained unchanged after adjustment for age and duration since immunization. Thus, in NH-Res, 2 vaccine shots were associated with a more pronounced immune response, whereas in HCWs, 1 or 2 vaccine shots in patients with COVID-19 history did make any difference. These results indicate significant differences in mRNA vaccination between NH-Res and middle-aged controls, and could contribute to the specification of vaccine policy in this very old, frail population.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04964024
Funding Statement
PIA project Lorraine Universite d Excellence reference ANR-15-IDEX-04-LUE and the FHU project CARTAGE-PROFILING (Aviesan 2021-2025).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Committee of the Nancy CHRU hospital made the statement that this research has been carried out in accordance to current French and European ethical standards as well as The Code of Ethics of the World Medical Association (Comite d Ethique CHRU de Nancy, decision numero 326, August 3, 2021).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This study was supported by the PIA project “Lorraine University of Excellence” reference ANR-15-IDEX-04-LUE, and the FHU CARTAGE-PROFILING project (Aviesan, 2021-2025). We thank Prof. Bruno Hoen and Dr. Ioannis Georgiopoulos for the critical review of the article. We also thank the staff of participating nursing homes and the Geriatric Department of the CHRU de Nancy for the conduction of the study in their establishments.
* Members of the “Lorraine Nursing Homes network on COVID-19 vaccine response” who contributed into this study: Denis Craus (EHPADs Le Clos Pré Saint Max, Sainte Sophie Thiaucourt, Joudreville les Bruyères and La Fontaine de Lincourt, Einville au Jard, Lorraine France), Marc Berr (EHPAD La Salle, Pompey, Lorraine, France), Thierry Colin (EHPAD, Les Sablons Pulnoy, Lorraine, France), Maurice Eckenfelder (EHPAD Chatel sur Moselle, Lorraine, France), Caroline Ferry-Bert (EHPAD L’Oseraie Laxou, Lorraine, France), Isabelle Gantois (USLD, CHRU Nancy, Lorraine France), Marie-Christine Godart (USLD, CHRU Nancy, Lorraine, France), Henri Rozenfarb (EHPAD, Hôtel Club Saint Max, Lorraine, France).
Data Availability
no